Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
In light of an aging population with increased cardiovascular comorbidity, the use of oral anticoagulation (OAC) is steadily expanding. A variety of pharmacological alternatives to vitamin K antagonists (VKA) have emerged over recent years (direct oral anticoagulants, DOAC, i.e., dabigatran, rivaroxaban, apixaban, and edoxaban) which show a reduced...
Alternative Titles
Full title
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b093a049edd04829ac8197cd6ebe4460
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b093a049edd04829ac8197cd6ebe4460
Other Identifiers
ISSN
1364-8535,1466-609X
E-ISSN
1364-8535,1466-609X,1366-609X
DOI
10.1186/s13054-019-2492-8
